For the quarter ending 2026-03-31, PCVX has $3,348,308K in assets. $352,294K in debts. $260,843K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 260,843 | 173,959 | 281,080 | 306,744 |
| Short-term investments | 1,476,335 | 1,387,000 | 1,430,240 | 1,354,683 |
| Prepaid expenses and other current assets | 76,310 | 66,402 | 55,847 | 54,348 |
| Total current assets | 1,813,488 | 1,627,361 | 1,767,167 | 1,715,775 |
| Property and equipment, net | 260,695 | 257,370 | 253,486 | 242,266 |
| Operating lease right-of-use assets | 113,103 | 116,009 | 83,515 | 85,649 |
| Long-term investments | 1,004,017 | 881,664 | 959,256 | 1,165,091 |
| Restricted cash | 1,466 | 1,466 | 1,468 | 1,319 |
| Other assets | 155,539 | 118,847 | 106,708 | 95,263 |
| Total noncurrent assets | 1,534,820 | 1,375,356 | 1,404,433 | 1,589,588 |
| Total assets | 3,348,308 | 3,002,717 | 3,171,600 | 3,305,363 |
| Accounts payable | 63,060 | 70,904 | 48,962 | 31,414 |
| Accrued compensation | 7,986 | 23,000 | 16,762 | 10,830 |
| Accrued contract manufacturing expenses | 134,704 | 74,654 | 103,959 | 73,726 |
| Accrued expenses | 30,247 | 31,068 | 24,592 | 32,214 |
| Operating lease liabilities current | 6,085 | 6,124 | 5,771 | 6,302 |
| Total current liabilities | 242,082 | 205,750 | 200,046 | 154,486 |
| Operating lease liabilities long-term | 110,212 | 111,357 | 78,672 | 79,543 |
| Other liabilities | - | 100 | - | - |
| Total liabilities | 352,294 | 317,207 | 278,718 | 234,029 |
| Common stock, 0.001 par value 500,000,000 shares authorized at march31, 2026 and december31, 2025 144,314,981 and 131,058,858 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 147 | 134 | 133 | 133 |
| Additional paid-in capital | 5,478,270 | 4,838,736 | 4,800,333 | 4,768,698 |
| Accumulated other comprehensive loss | -6,834 | 1,587 | 856 | -1,887 |
| Accumulated deficit | -2,475,569 | -2,154,947 | -1,908,440 | -1,695,610 |
| Total stockholders' equity | 2,996,014 | 2,685,510 | 2,892,882 | 3,071,334 |
| Total liabilities and stockholders' equity | 3,348,308 | 3,002,717 | 3,171,600 | 3,305,363 |
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX)